2Spaeth GL. Ophthalmic surgery principles and practice[ M ]. Philadelphia: Saunders, 1982 : 246- 347.
3Kronfeld PC. The chemical demonstration of transeonjunetival passage of aqueous after antiglaueomatous operations[ J]. Am J Ophthaimol,1952,35(3) : 38.
4Strauss GH, Dunn ET, Dunn RC, et al. Subconjunctival high dose plasminogen activator in rabbit filtration surgery. J Ocul Pharma- col, 1991, 7: 9-19.
5Heuer DK, Parrish RK, Gressel MG, et al. 5-fluorouracil and glau- coma filtering surgery. IL A pilot study. Ophthalmology, 1984, 91: 384-394.
6Heuer DK, Parrish RK, Gressel MG, et al. 5-Fluorouracil and glau- coma filtering surgery. Ⅲ. Intermediate follow-up of a pilot study. Ophthalmology, 1986, 93: 1537-1546.
7Lansiaux A, Facompre M, Wattez N, et al. Apoptosis induced by the homocamptothecin anticancer drug BN80915 in HL-60 cells. Mol Pharmacol, 2001, 60: 450-461.
8Sun Y, Wang I,, Sun S, et al. The Effect of 10-hydroxycamp- tothecine in preventing fibroblast proliferation and epidural scar adhesion after laminectomy in Rats. Eur J Pharmacol, 2008, 593: 44-48.
9Yoon PS, Singh K. Update on antifibrutic use in glaucoma surgery, including use in trabeculectomy and glaucoma drainage implants and combined cataract anti glaucoma surgery. Curr Opin Ophthal- tool, 2004, 15: 141-146.
10DeBry PW, Perkins TW, Heatley G, et al. Incidence of late-onset bleb-related complications following trabeculectomy with mito- mycin. Arch Ophthalmol, 2002, 120: 297-300.
